Have you read the FTC's complaint about pharmacy benefit managers and insulin prices? Learn how PBM business practices hurt pharmacies and American patients.

CBP published a summary of what they and agents with the FDA found in a week looking for fake medicines at the Port of Cincinnati. Let’s take a look at what they found.

Prescription Drug Affordability Boards (PDABs) has started popping up in states looking to establish upper payment limits on prescription drug prices. But will they also create barriers to medication access? Listen to PSM's Executive Director Shabbir Safdar and CEO of the National Alliance of State Pharmacy Associations, Krystalyn Weaver's conversation with Brian Mayo, Executive Director of the Oregon State Pharmacy Association, and Leah Lindahl, VP for Government Affairs at the Healthcare Distribution Association as they discuss what PDABs could do to an already stressed independent pharmacy community.

Listen to Mark Karhoff of Ten Count Consulting and PSM's Executive Director Shabbir Safdar explain the reasoning behind the FDA announced exemptions for connected trading partners and small dispensers as the agency approaches the full implementation of the Drug Supply Chain Security Act.

Mexican border pharmacies have a long tradition of selling U.S. tourist fake medicine, and a recent Reuters piece shows that they're selling counterfeit Ozempic, too.

When/how did counterfeit Botox turn into a full-blown public health emergency in the United States?

You would think injunctions and expensive settlements would stop black market HIV drug schemes, especially after some schemers were jailed. You would be wrong about that.

Don't inject yourself with anything bought via social media. That goes double for receiving injections from someone who bought them on the darkweb.